Fingerpaint, a full-service marketing agency with headquarters based in Saratoga Springs, New York, has opened an office in Columbus, Ohio.
Connecticut and 19 other states filed a lawsuit against Mylan, Teva Pharmaceuticals and four other generic drug makers saying they entered into illegal conspiracies that raised prices on two common generic drugs, the New York state attorney general’s office said in a statement.
EU lawmakers urged Germany to grant broader access for other Europeans to its fund for thalidomide victims and for the drug’s manufacturer to provide proper compensation and care to victims not yet recognized.
Intouch Solutions has announced the promotion of six employees in its Chicago office.
Lonza Group announced its biggest-ever acquisition with a deal to buy Capsugel, a U.S. maker of capsule products and other drug delivery systems, for $5.5 billion in cash to broaden its product range as a pharmaceuticals industry supplier.
Regeneron Pharmaceuticals is continuing to expand its physical footprint in New York’s Hudson Valley. The company snapped up a 76-acre site for $50 million, the Journal News reported.
Pfizer and Astellas Pharma announced that Xtandi (enzalutamide) did not meet its top-line results in a Phase IV clinical trial.
Although in general there are plenty of jobs in the life sciences, certain areas seem to be trending upward. Paul Strouts, global managing director of Hays Life Sciences – a worldwide recruiting firm – recently selected five areas that deserve special notice.
A Pfizer Inc. ointment to treat mild to moderate cases of the itchy skin condition eczema, or atopic dermatitis, won U.S. approval for use in patients aged 2 years and older, the Food and Drug Administration said.
Express Scripts Holding Co. – the largest pharmacy benefit manager in the United States – signaled that scrutiny into drug pricing is not going away.
Intercept Pharmaceuticals Inc. said its liver drug received conditional approval from the European Commission to treat patients with primary biliary cholangitis (PBC).
Siemens Healthineers plans to invest approximately $300 million into its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility to increase its manufacturing footprint in the United States.
INC Research Holdings, a contract research organization, is planning a $37.9 million investment as the company shifts from Raleigh to a new Morrisville, N.C. headquarters. The move to a larger facility will create an additional 550 jobs over the next several years, the company said.
Two leading U.S. medical societies are poised to issue new diabetes treatment guidelines that are expected to reflect the lifesaving cardiovascular effects of Eli Lilly’s Jardiance.
U.S. researchers have found evidence of the Zika virus replicating in fetal brains for up to seven months after the mother became infected with the virus, and they showed the virus can persist even after birth, according to a published study.
Veterans with posttraumatic stress disorder (PTSD) who have difficulties making it to in-person therapy sessions may be able to get treatment that is just as good by videoconference.
Bristol-Myers Squibb Company announced important changes to its U.S. geographic footprint that will strengthen capabilities of the company’s R&D hubs of world-class science and innovation in Central New Jersey, the San Francisco Bay Area and Cambridge, Massachusetts while further integrating biologics development with clinical manufacturing at key sites to foster greater speed and collaboration.
Eli Lilly and Co. said certain patients using its insulin products via a partnership with Express Scripts Holding Co. could secure a discount of up to 40 percent.
The global pharmaceuticals industry is set to win the lowest annual number of new drug approvals in 2016 since 2010.
Proteon Therapeutics Inc. said its experimental chronic kidney disease drug failed to meet the main goal in a late-stage study.